RecruitingNCT06643741

Non-Invasive Preeclampsia Screening and Biobank

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sequenom, Inc.
Principal Investigator
Emily Rosenfeld, DO
Rutgers Robert Wood Johnson Medical School
Enrollment
6550 target
Eligibility
18 years · FEMALE
Timeline
20252026

Study locations (21)

Collaborators

Rutgers Robert Wood Johnson Medical School · Laboratory Corporation of America

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06643741 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials